Current Net Margin
-3043.01%
Kymera Therapeutics, Inc. currently has a net profit margin of -3043.01%.
Financial Fundamentals
KYMR • Quarterly Data • 5Y View
Historical Margin Data
| Date | Rev ($B) | NI ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-12-31 | 0.00 | -0.09 | -3043.01% | ▼6996 |
| 2025-09-30 | 0.00 | -0.08 | -2973.05% | ▼230544 |
| 2025-06-30 | 0.01 | -0.08 | -667.60% | ▼37086 |
| 2025-03-31 | 0.02 | -0.07 | -296.75% | ▲66014 |
| 2024-12-31 | 0.01 | -0.07 | -956.88% | ▲71344 |
| 2024-09-30 | 0.00 | -0.06 | -1670.33% | ▼150634 |
| 2024-06-30 | 0.03 | -0.04 | -163.98% | ▲30804 |
| 2024-03-31 | 0.01 | -0.05 | -472.02% | ▼44202 |
| 2023-12-31 | 0.05 | -0.01 | -30.01% | ▲108816 |
| 2023-09-30 | 0.00 | -0.05 | -1118.17% | ▼88321 |
| 2023-06-30 | 0.02 | -0.04 | -234.96% | ▲19741 |
| 2023-03-31 | 0.01 | -0.04 | -432.37% | ▼21634 |
| 2022-12-31 | 0.02 | -0.03 | -216.03% | ▲23421 |
| 2022-09-30 | 0.01 | -0.04 | -450.24% | ▼10060 |
| 2022-06-30 | 0.01 | -0.04 | -349.64% | ▲3162 |
| 2022-03-31 | 0.01 | -0.04 | -381.25% | ▼15931 |
| 2021-12-31 | 0.02 | -0.03 | -221.94% | ▼8139 |
| 2021-09-30 | 0.02 | -0.03 | -140.55% | ▼739 |
| 2021-06-30 | 0.02 | -0.02 | -133.16% | ▼6325 |
| 2021-03-31 | 0.02 | -0.01 | -69.91% | ▲2931 |
| 2020-12-31 | 0.01 | -0.01 | -99.22% | ▼4427 |
| 2020-09-30 | 0.01 | -0.01 | -54.95% | ▲37051 |
| 2020-06-30 | 0.00 | -0.01 | -425.46% | ▼10655 |
| 2020-03-31 | 0.00 | -0.01 | -318.90% | ▲30919 |
| 2019-12-31 | 0.00 | -0.01 | -628.10% | ▲57401 |
| 2019-09-30 | 0.00 | -0.01 | -1202.11% | — |
* Basis Point (bps) change measures sequential efficiency shifts. 100 bps = 1.00% Margin change.